Morgan Stanley Receives 'Hold' Rating from Analysts

Analysts cite mixed outlook for the financial services firm

Apr. 15, 2026 at 6:43am

Got story updates? Submit your updates here. ›

A highly detailed, cinematic close-up image of heavy, industrial banking equipment and machinery in shades of steel, bronze, and chrome, conveying the tangible power and security of a major financial institution.An extreme close-up of the inner workings of a major financial institution, reflecting the complex machinery that powers the global economy.San Diego Today

Morgan Stanley (NYSE:MS) has received an average 'Hold' rating from 19 research analysts currently covering the stock, according to MarketBeat. Eleven analysts have rated the stock as 'Hold', while eight have given it a 'Buy' rating. The average 12-month price target among the analysts is $189.94.

Why it matters

Morgan Stanley's stock rating and price target from Wall Street analysts provide insight into the firm's near-term performance outlook and investor sentiment. A 'Hold' rating suggests analysts see a mixed picture, with potential upside balanced by risks or uncertainties.

The details

The analysts' ratings and price targets for Morgan Stanley stock reflect a range of views on the company's prospects. While some see potential for the stock to rise, others believe it will hold steady around current levels. Factors like the firm's business mix, market conditions, and competitive dynamics likely play a role in the analysts' assessments.

  • The analyst ratings and price targets were reported on April 15, 2026.

The players

Morgan Stanley

A global financial services firm headquartered in New York City, providing investment banking, securities, wealth management, and investment management services.

Got photos? Submit your photos here. ›

The takeaway

Morgan Stanley's mixed analyst ratings suggest the firm faces a balanced outlook, with potential upside balanced by risks. Investors will likely monitor the company's performance and any changes in analyst sentiment in the coming quarters.